Holen Sie sich die Stockscreener-App
323.37
0.42%
-1.38
Krystal Biotech Inc Aktie (KRYS) Neueste Nachrichten
KRYS Stock Rallies On Upbeat Earnings: Jefferies Ups Price Target On Sustained Vyjuvek Optimism - Stocktwits
Krystal Biotech, Inc. (KRYS) Stock Analysis: Evaluating the 31.9% Revenue Growth and Its Implications for Investors - DirectorsTalk Interviews
Krystal Biotech, Inc. (KRYS) tops Q1 earnings and revenue estimates - MSN
Krystal Biotech stock soars 16% in three months: Here's why - MSN
Krystal Biotech stock hits all-time high at 319.6 USD By Investing.com - Investing.com Nigeria
Krystal Biotech stock hits all-time high at 319.6 USD - Investing.com
Cash per share of Krystal Biotech, Inc. – MUN:4KB - TradingView
This Insider Has Just Sold Shares In Krystal Biotech - simplywall.st
Is the options market predicting a spike in Krystal Biotech stock? - MSN
Krystal Biotech, Inc. (KRYS) Stock Analysis: Strong Buy Ratings and a Promising 7.24% Potential Upside - DirectorsTalk Interviews
Krystal Biotech Insider Sold Shares Worth $7,702,984, According to a Recent SEC Filing - marketscreener.com
Is Krystal Biotech, Inc. (KRYS) A Good Stock To Buy Now? - Insider Monkey
Krystal Biotech, Inc. Cash Flow – XETR:4KB - TradingView
Krystal Biotech, Inc. Balance Sheet – XETR:4KB - TradingView
ETFs Investing in Krystal Biotech, Inc. Stocks - TradingView
Krystal Biotech CEO Krishnan sells $7.7m in company stock By Investing.com - Investing.com South Africa
Krystal Biotech CEO Krishnan sells $7.7m in company stock - Investing.com UK
Krystal Biotech R&D president Suma Krishnan sells $7.7m in stock By Investing.com - Investing.com South Africa
Krystal Biotech(KRYS.US) 10% Shareholder Sells US$7.7 Million in Common Stock - Moomoo
Krystal Biotech R&D president Suma Krishnan sells $7.7m in stock - Investing.com Canada
25K-share sale by Krystal Biotech (NASDAQ: KRYS) R&D head - Stock Titan
Krystal Biotech (KRYS) CEO trades 25,000 shares under 10b5-1 plan - Stock Titan
Krystal Biotech Inc stock (US5012681064): shares steady after strong Q1 2026 earnings momentum - AD HOC NEWS
Is the Options Market Predicting a Spike in Krystal Biotech Stock? - Zacks Investment Research
The Technical Signals Behind (KRYS) That Institutions Follow - Stock Traders Daily
[144] Krystal Biotech, Inc. SEC Filing - Stock Titan
Krystal Biotech Stock Soars 16% in Three Months: Here's Why - The Globe and Mail
KRYS Technical Analysis | Trend, Signals & Chart Patterns | KRYSTAL BIOTECH INC (NASDAQ:KRYS) - ChartMill
Why is Krystal Biotech (KRYS) up 3% since last earnings report? - MSN
Why Is Krystal Biotech (KRYS) Up 3% Since Last Earnings Report? - Yahoo Finance
Analysts Have Conflicting Sentiments on These Healthcare Companies: Krystal Biotech (KRYS), AbbVie (ABBV) and Tempus AI, Inc. Class A (TEM) - The Globe and Mail
KRYS Reiterates by HC Wainwright & Co. -- Price Target Maintained at $310 - GuruFocus
Krystal Biotech, Inc. (KRYS) Stock Analysis: A Biotech Powerhouse with 31.90% Revenue Growth and Potential Upside - DirectorsTalk Interviews
BofA Securities Maintains Krystal Biotech(KRYS.US) With Buy Rating, Maintains Target Price $364 - Moomoo
Krystal Biotech (BSP:K1YS34) Equity Investments - GuruFocus
KRYS Technical Analysis & Stock Price Forecast - Intellectia AI
Exploring High Growth Tech Stocks In The US Market May 2026 - simplywall.st
Insider Sell: John Thomas Sells Shares of Krystal Biotech Inc (K - GuruFocus
Insider Sell: John Thomas Sells Shares of Krystal Biotech Inc (KRYS) - GuruFocus
Krystal Biotech EVP, general counsel sells $193,903 in shares - Investing.com
Krystal Biotech EVP, general counsel sells $193,903 in shares By Investing.com - Investing.com Australia
1.27%
1.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):